Table 1. Prognostic relevance of clinicopathological variables in univariate and multivariate survival analyses in 154 patients with advanced serous ovarian cancer.
|
Recurrence-free survival
|
Overall survival
|
|||||
|---|---|---|---|---|---|---|
| Univariate |
Multivariate
|
Univariate |
Multivariate
|
|||
| P-value | HR (95% CI) | P-value | P-value | HR (95% CI) | P-value | |
| Age (years) | ||||||
| ⩽57 vs >57a | 0.309 | 1.005 (0.987–1.023) | 0.603 | 0.042 | 1.022 (0.995–1.050) | 0.042 |
| Tumour stage | ||||||
| III vs IV | <0.001 | 2.378 (1.488–3.799) | <0.001 | 0.014 | 2.048 (1.031–4.066) | 0.014 |
| Tumour grade | ||||||
| I/II vs III | 0.017 | 1.558 (0.963–2.520) | 0.071 | 0.046 | 1.751 (0.801–3.828) | 0.046 |
| Residual disease | ||||||
| 0 vs >0 | 0.001 | 1.779 (1.175–2.692) | 0.006 | 0.118 | 1.614 (0.870–2.994) | 0.118 |
Abbreviations: CI=confidence interval; HR=hazard ratio.
a
Median age at diagnosis was 57 years.